Use of FasL or CD4 + / FasL- / TH1 cell lines transfected with FasL for the treatment of TH1 / TH2 diseases, process for the production of CD4 + / FasL + / TH1 cell lines and substance compositions of FasL and one or more cytokines and its use for the treatment of TH1 / TH2 diseases

摘要

Disclosed are the use of FasL as active pharmacological component in the treatment of TH1/TH2 diseases, compositions containing FasL and one or more cytokines, specially interferon- gamma , the use of a composition according to claims 11 and 12 for the treatment of TH1/TH2 diseases, the use of autologous Cd4+/FasL-/TH1 cell lines of the patient, transfected with the FasL gene sequence or with physiologically active fragments of the FasL gene sequence for the treatment of TH1/TH2 diseases.